Extended Executive Management

Dr. Nadezda Gracheva is a scientist with a background in Radiochemistry and Radiopharmacy as a branch of Nuclear Medicine. She obtained a Ph.D. degree at ETH Zurich, where she was responsible for the development of novel radioactive nuclides for Targeted Radionuclide Therapy to promote innovative cancer treatments.

Dr. Aurélie Jenn, Head of Regulatory Affairs and Quality Assurance, is a pharmacist (Pharm. D) bringing over 20 years of experience in the pharmaceutical industry. In a first part of her career, she worked in Regulatory Affairs / CMC writing for generic products and New Chemical Entities in Switzerland and France, having close interactions and providing support to technical departments.

Debora Foglia joined the company as Legal Counsel of Swiss Rockets AG and its subsidiary companies in January 2023. She is an attorney-at-law and holds a bachelor’s and master’s degree in law of the University of Basel.

Beat Ritschard is a skilled senior executive with over 35 years of experience in the pharma and biotech industry. He has recently joined Swiss Rockets as Head of Financial Planning & Controlling, where he will oversee budgeting, controlling, planning and other strategic projects.

Jörg Honegger, a highly experienced attorney with over 30 years of practical legal experience in consulting and litigation, has been serving as interim General Counsel of Swiss Rockets Incubator and its subsidiary companies.

Dr. Janet Dawson has a substantial academic and professional background in research and drug development, with expertise spanning areas of pharmacology, inflammation, rheumatology, and various experimental techniques.

Dr. Robert Ettlin is the Head of Preclinical Safety in Swiss Rockets. After some years in toxicological pathology at F. Hoffmann La Roche Ltd., Ettlin joined Sandoz Ltd. in Basel, where he advanced to Head of Toxicology and later Head of Development Operations Switzerland.

Dr. Christoph Heusser, Head of Immunology, is an immunology expert who pioneered antibody-based therapies and antibody-mediated effector functions. He was Head of Immunology at Ciba-Geigy and Head of the Transplantation- Immunology Unit at Novartis and gave lectures on antibody-based interventions at the University Basel for 15 years.

Maciej Talarek, Financial Advisor, started his career in the insurance industry. As a result, he specialized in accounting and found his future in the fiduciary sector.

Michel Petignat, Head of Human Resources, is a qualified HR Specialist in the Life Sciences industry. During his long and outstanding professional career, Michel worked as an HR Manager in leading pharma and biotech companies such as Sandoz, Novartis Pharma, Syngenta Crop Protection and Actelion Pharmaceuticals.

Dr. Bernhard Hostettler, Head of Intellectual Property, originally is an organic chemist. After his Ph.D. at ETH Zürich, Bernhard was active in research for more than 20 years with companies Roche, CIBA, Syngenta and Givaudan.